Jayakanth Kankanala

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Novel HIV-1 capsid-targeting small molecules of the PF74 binding site”.

Novel HIV-1 capsid-targeting small molecules of the PF74 binding site

European Journal of Medicinal Chemistry(2020)10.1016/j.ejmech.2020.112626

N/A

0DataRank · unranked

28 citations

Mary C. Casey, Sanjeev Kumar V. Vernekar, Rajkumar Lalji Sahani, Jayakanth Kankanala, Karen A. Kirby +8 more

Discovery of N-benzyl hydroxypyridone carboxamides as a novel and potent antiviral chemotype against human cytomegalovirus (HCMV)

Acta Pharmaceutica Sinica B(2021)10.1016/j.apsb.2021.08.019

N/A

0DataRank · unranked

11 citations

Tiffany C. Edwards, Jayakanth Kankanala, Yan Wang, Rajkumar Lalji Sahani, Jiashu Xie +3 more

Repurposing N-hydroxy thienopyrimidine-2,4-diones (HtPD) as inhibitors of human cytomegalovirus pUL89 endonuclease: Synthesis and biological characterization

Bioorganic Chemistry(2022)10.1016/j.bioorg.2022.106198

N/A

0DataRank · unranked

5 citations

Tiffany C. Edwards, Ryuichi Majima, Eunkyung Jung, Jayakanth Kankanala, Jiashu Xie +3 more